This Bull Cheers: Valeant Pharmaceuticals May Be Knocking Out One of Its Biggest Stock Overhangs

Valeant Pharmaceuticals (NYSE:VRX) shares continue to surge another 6% today after getting fired up 17% from yesterday’s third quarter outclass. Cantor analyst Louise Chen predicts a boost in investor appreciation could lead to favorable earnings revisions among other bullish strides forward.

Story Continues